Mesenchymal Stromal Cells (MSCs) |
Differentiation into specific cell lineages, modulating local microenvironment through paracrine/autocrine signals |
Promote tendon healing, reduce inflammation, and improve structural integrity. |
[189,[223], [224], [225], [226], [227], [228], [229], [230]] |
Bone Marrow-Derived MSCs (BM-MSCs) |
Anti-inflammatory properties, IL-1Ra secretion, collagen deposition enhancement |
Improved biomechanical properties, collagen fiber organization, and early tendon healing. |
[189,[231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245]] |
Adipose Tissue-Derived MSCs (AT-MSCs) |
Easy isolation, differentiation into multiple cell types, anti-inflammatory properties |
Enhance tendon healing and reduce inflammation. |
[189,[246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260]] |
Platelet-Rich Plasma (PRP) |
Concentrated platelets release growth factors and cytokines |
Stimulate healing processes, improve pain, and enhance tendon function. |
[189,[261], [262], [263]] |
Gene Therapy |
Targeting specific genes involved in tendon repair and regeneration |
Potential to correct genetic predispositions and enhance tendon healing processes. |
[189,264,265] |
Scaffold-Based Therapies |
Use of biocompatible materials to provide structural support and deliver cells/growth factors |
Promote tissue regeneration and structural support for tendon repair. |
[189,[266], [267], [268]] |